创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

ZHANG Xinlu, CUI Nan, QIU Neng. Advances in Research on Biotin in Tumor Targeted Drug Delivery[J]. Progress in Pharmaceutical Sciences, 2023, 47(2): 118-124. DOI: 10.20053/j.issn1001-5094.2023.02.006
Citation: ZHANG Xinlu, CUI Nan, QIU Neng. Advances in Research on Biotin in Tumor Targeted Drug Delivery[J]. Progress in Pharmaceutical Sciences, 2023, 47(2): 118-124. DOI: 10.20053/j.issn1001-5094.2023.02.006

Advances in Research on Biotin in Tumor Targeted Drug Delivery

  • Currently, targeted drug delivery system is an effective method to treat cancer, and the selection of targeted ligands is the key of targeted drug delivery. Biotin receptors are over-expressed on the surface of most tumor cells, but lowly or under-expressed in normal cells. This article briefly introduces biotin and biotin receptors, and further reviews the research progress of diagnosis and treatment of cancer using biotin modified liposomes, micelles, nanoparticles and other drug delivery systems in order to provide reference for related research and clinical application.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return